ORTEC OPTIMIZATION TECHNOLOGY BV

Their core work

ORTEC is a Dutch operations research and optimization software company that builds decision-support systems for complex planning, scheduling, and logistics problems. Their commercial products cover vehicle routing, workforce scheduling, and supply chain optimization for large enterprises and public-sector clients. In EU research, they contribute applied expertise in mathematical optimization, automated machine learning, and cyber-physical systems — bridging academic algorithm development and industrial deployment. In AIDPATH, they applied this capability to hospital bioprocess automation, specifically the AI-driven manufacturing of CAR-T cell therapies.

What they specialise in

How they've shifted over time

ORTEC's first H2020 involvement (MINOA, 2018–2021) was a Marie Curie training network focused on pure mathematical optimization — non-linear, mixed-integer programming — where ORTEC served as an industry partner validating academic algorithms against real planning problems. Their second project (AIDPATH, 2021–2025) marks a clear shift toward applied AI in life sciences: automated machine learning, digital twins, IoT, and hospital bioprocess control for personalized medicine. The trajectory moves from mathematical foundations toward deployed AI systems in highly regulated, mission-critical environments.

ORTEC is moving from theoretical optimization research toward end-to-end AI automation in complex real-world systems, with life sciences and smart manufacturing emerging as their primary application frontier.

How they like to work

ORTEC consistently joins consortia as a specialist partner rather than a coordinator, contributing commercial software capabilities and applied optimization know-how to research-led projects. Their two projects show a pattern of pairing with academic-led consortia where ORTEC provides the industry validation and deployment bridge. With 32 unique partners across 10 countries from just two projects, they engage in broad, multi-stakeholder consortia rather than tight bilateral partnerships.

ORTEC has built connections with 32 distinct partners across 10 countries through two projects, an unusually wide network for such a small H2020 footprint. Their reach is European, reflecting the multi-national consortia typical of MSCA and Innovation Action schemes.

What sets them apart

ORTEC occupies a rare position as a commercial optimization software company — not a consultancy or university — that engages in frontier EU research on automated machine learning and cyber-physical systems. This means they bring production-grade, commercially tested optimization engines into research consortia, rather than prototypes. For consortium builders, ORTEC offers the credibility of a market-facing software company with genuine algorithmic depth, which strengthens both the innovation and exploitation sections of a project proposal.

Highlights from their portfolio

• AIDPATH
  The largest funded project (€797,827 EC contribution) and the most technically distinctive — applying AI automation, digital twins, and IoT to decentralized CAR-T cell therapy manufacturing inside hospitals, a highly complex domain that combines advanced therapies, regulatory constraints, and real-time process control.
• MINOA
  Participation in a Marie Curie training network for mixed-integer non-linear optimization signals ORTEC's role as an industry anchor for doctoral-level research, giving them influence over the next generation of optimization researchers in Europe.